Combining ctDNA and utDNA as a Dual Biomarker-driven Strategy for Bladder-sparing Therapy in Muscle-invasive Bladder Cancer: Neither Alone Is Sufficient

IF 29.1 1区医学 Q1 UROLOGY & NEPHROLOGY

European urology Pub Date : 2026-09-01 Epub Date: 2026-05-16 DOI:10.1016/j.eururo.2026.04.030

José Daniel Subiela, Daniel A. González-Padilla, Renate Pichler, Pietro Scilipoti, Benjamin Pradere

引用次数: 0

查看原文本刊更多论文

联合ctDNA和utDNA作为双生物标志物驱动的策略用于肌肉浸润性膀胱癌的膀胱保留治疗：单独使用都不够。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology 医学-泌尿学与肾脏学

CiteScore

43.00

自引率

2.60%

发文量

1753

审稿时长

23 days

期刊介绍： European Urology is a peer-reviewed journal that publishes original articles and reviews on a broad spectrum of urological issues. Covering topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, the journal also highlights recent advances in techniques, instrumentation, surgery, and pediatric urology. This comprehensive approach provides readers with an in-depth guide to international developments in urology.